ISNAENI, Faizatul ROSYIDAH, Ni Made MERTANIASIH

Evaluation of IFN-γ level in peripheral blood mononuclear cell of childhood tuberculosis treated by lactic acid bacteria multi cultures

At least a half million children in the world are suffering from TB every year and 64.000 children diedfrom TB in 2011. Previous works indicated the ability of probiotic in stimulating the production of IL-12 and IFN-γwhich subsequently increased the role of type Th1 responses and improved the balance of Th1-Th2. Antigencombination of Mycobacterium tuberculosis (Mtb) and Lactic Acid Bacteria (LAB) initiated synergistic increase of IFN-γbigger than the level induced by Mtb or LAB. This study aimed to analyze the administration effects of LAB multicultures (Lactobacillus acidophilus, Lactobacillus bulgaricus, Lactobacillus casei, Bifidobacterium bifidum, Bifidobacteriumanimalis, Lactobacillus plantarum, Streptococcus thermophilus) to the secretion of IFN-γ on peripheral blood mononuclearcell (PBMC) culture supernatant of childhood tuberculosis patients under medication. The PBMC of the patientsisolated from whole blood was culture-treated in 4 groups: (1) without treatment (-MtbCell, -LAB), (2) incubation withMtb, without LAB administration (+MtbCell, -LAB), (3) with LAB administration, without incubation with Mtb(-MtbCell, +LAB), and (4) incubation with Mtb and LAB administration (+MtbCell, +LAB), to subsequently be taken thesupernatant and to examine IFN-γ by using enzyme-linked immunosorbent assay. There was a significant difference inIFN-γ assay (p = 0.006) between group (1) compared to the group (4). Addition of the LAB multi cultures increasedthe secretion of IFN-γ supernatant on the PBMC culture supernatant of childhood tuberculosis patients undermedication. The LAB increased 6.31% of IFN-γ level, while treatment with LAB and Mtb increased IFN-γ level up to15.79% compared to IFN- γ level in the PBMC without treatment.

PDF

___

[1] WHO Tuberculosis. http://www.who.int/mediacentre/factsheets/fs104/en/, (accessed on 6 June 2019).
[2] WHO Global tuberculosis report 2012. https://www.who.int/tb/publications/global_report/gtbr12_main.pdf, (accessed on 06 June 2019)
[3] WHO No more crying, no more dying towards zero TB deaths in children. http://www.stoptb.org/assets/documents/news/ChildhoodTB_report_singles.pdf, (accessed on 17 June 2019).
[4] Kumar V, Abbas KA, Fausto N, Robbins and Cotran Pathologic Basis of Disease, Eighth ed., Elsevier Saunders, Philadelphia, PA, US, 2010.
[5] Bhavanam S, Gina RR, Monika K, Dennis K, Steven JD. Characterization of immune responses of human PBMCs infected with Mycobacterium tuberculosis H37Ra: Impact of donor declared BCG vaccination history on immune responses and M. tuberculosis growth. Plos One. 2018; 13(9): e0203822. [CrossRef]
[6] Joost JO. Cytokines. In: Tristram GP, Daniel PS, Abba IT. (Eds). Medical Immunology, tenth ed., McGraw-Hill Medical Publishing Division, New York, 2001, pp. 95-112.
[7] Ghadimi D, de Vrese M, Heller KJ, Schrezenmeir J. Lactic acid bacteria enhance autophagic ability of mononuclear phagocytes by increasing Th1 autophagy-promoting cytokine (IFN-gamma) and nitric oxide (NO) levels and reducing Th2 autophagy-restraining cytokines (IL-4 and IL-13) in response to Mycobacterium tuberculosis antigen. Int Immunopharmacol. 2010; 10(6): 694-706. [CrossRef]
[8] Crevel V, Tom HM, Ottenhoff, Jos WM. Innate immunity to Mycobacterium tuberculosa. Clin Microbiol Rev. 2002; 15(2): 294-309. [CrossRef]
[9] Terapi imuno potensiasi atau terapi imunomodulator. https://childrenallergyclinic.wordpress.com/2010/10/23/terapi-imunopotensiasi-atau-imunomoduLasi/, (accessed on 9 June 2019).
[10] Isolauri E, Salminen S. Probiotics: use in allergic disorders: a nutrition, allergy, mucosal immunology, and intestinal microbiota (NAMI) research group report. J Clin Gastroenterol. 2008; 42(2): 91–96. [CrossRef]
[11] Isolauri EY, Sütas P, Kankaanpää, Arvilommi H, Salminen S. Probiotics: effects on immunity. Am J ClinNutr.2001; 73(2): 444 – 450. [CrossRef]
[12] Isnaeni I, Idha K, Sugiyartono, Agus SR. Efek imunomodulator kombinasi susu probiotik (Lactobacillus acidophillus) dan ekstrak daun jambu biji. Jurnal Farmasi Indonesia. 2016; 8(1): 277-282. [CrossRef]
[13] Isnaeni, S. Antibacterial activities of probiotics mixed culture against methicillin resistant Staphylococcus aureus (MRSA) and extended spectrum beta lactamase (ESBL) bacteria. J Chem Pharm. 2015; 7(4): 1005-1010.
[14] Isnaeni, Maulidina A, Kusumawati I, Setyawatie EM. Inhibitory activity of Lactobacillus plantarum ATCC8014 fermented milk with aqueous combined extract of Moringaoleifera leaves against Streptococcus mutans. J Res Pharm. 2019; 23(4): 701-710. [CrossRef]
[15] Dao DN. Mycobacterium tuberculosis lipomannan inducer apoptosis and interleukin-12 production in macrophages. Infect Immun. 2004; 72(4): 2067-2074. [CrossRef]
[16] Gackowska l, Michalkiewicz J, Krotkiewski, Helmin-Basa A, Kubiszewska I, Dzierzanowska D. Combined effect of different lab strains on the mode of cytokines pattern expression in human peripheral blood mononuclear cells. J Physiol Pharmacol. 2006; 57(9): 13-21.
[17] MACS Cell Separation Reagents data sheets, Miltenyi Biotec GmbH 2008. https://www.miltenyibiotec.com, (accessed on 14 May 2019).
[18] Departemen Kesehatan RI-IDAI, Diagnosis dan Tatalaksana Tuberkulosis anak, Departemen Kesehatan Republik Indonesia, Jakarta, JKT, ID, 2008.
[19] Dian DA. Magister Thesis. Pengaruh bakteri probiotik dari berbagai sumber terhadap aktivitas imunoglobulin g (IgG) pada mencit jantan (Mus musculus). Faculty of Pharmacy, Universitas Hasanuddin, Tamalanrea, Makassar, Indonesia, 2011.
[20] Linawati M, Baginda M, Pengaruh propolis terhadap sekresi interleukin-12 pada supernatant kultur makrofag dari penderita tuberculosis paru yang diinfeksi Mycobacterium tuberculosis, RSUP Sanglah Denpasar Bali, Denpasar, DPS, ID, 2006.
[21] R&D System, Technical Datasheet. Quantikine Human IFN-γ Immunoassay. For the quantitative determinations in cell culturesupernates, serum, and plasma. Catalog Number DIF 50, R&D Systems Inc, Minneapolis, MN, US, 2018.